Charles River Laboratories | CRL - Trade Creditors

Stock Price
173.73
Daily Change
3.93 2.31%
Monthly
8.77%
Yearly
50.96%
Q2 Forecast
166.17

Charles River Laboratories reported $148.8M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Agilent USD 602M 32M Dec/2025
Align Technology USD 121.45M 4.1M Dec/2025
Bio-Rad Laboratories USD 129M 200K Dec/2025
Bruker USD 215.9M 31.5M Dec/2025
Cardinal Health USD 39B 2.14B Dec/2025
Charles River Laboratories USD 148.8M 20.82M Dec/2025
Cigna USD 10.66B 1.31B Dec/2025
Concord Medical Services Hldg CNY 112.19M 19.4M Jun/2025
CVS Health USD 59.38B 1.56B Dec/2025
Danaher USD 1.79B 54M Mar/2026
Dentsply International USD 300M 32M Dec/2025
Elevance Health USD 6.21B 10.88B Mar/2026
Galapagos EUR 104.65M 4.02M Dec/2025
Humana USD 5.72B 198M Dec/2025
Illumina USD 240M 22M Dec/2025
Incyte USD 1.63B 1.46B Dec/2025
Intrexon USD 4.85M 3.12M Jun/2024
IQVIA Holdings USD 3.75B 201M Dec/2025
Laboratory Of America USD 840.8M 172.3M Dec/2025
Lonza CHF 471M 3M Dec/2024
McKesson USD 60.68B 255M Dec/2025
Merck EUR 2.11B 182M Dec/2025
Mettler Toledo International USD 266.63M 19.22M Dec/2025
Novartis USD 4.46B 99M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Quest Diagnostics USD 1.5B 100M Mar/2026
Revvity USD 185.46M 9.66M Dec/2025
Thermo Fisher Scientific USD 3.62B 502M Dec/2025
United Therapeutics USD 7.1M 460.9M Dec/2025
UnitedHealth USD 77.37B 37.19B Dec/2025
Veradigm USD 30.84M 18.23M Dec/2022
Waters USD 103.78M 11.95M Dec/2025
West Pharmaceutical Services USD 252.3M 1.4M Mar/2026